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Abstract
Progestins bind to the progestin receptor (PR) isoforms, PR-A and PR-B, in brain to influence development,
female reproduction, anxiety, and stress. Hormone-activated PRs associate with multiple proteins to form
functional complexes. In the present study, proteins from female mouse hypothalamus that associate with PR
were isolated using affinity pull-down assays with glutathione S-transferase–tagged mouse PR-A and PR-B.
Using complementary proteomics approaches, reverse phase protein array (RPPA) and mass spectrometry, we
identified hypothalamic proteins that interact with PR in a ligand-dependent and isoform-specific manner and
were confirmed by Western blot. Synaptic proteins, including synapsin-I and synapsin-II, interacted with agonist-
bound PR isoforms, suggesting that both isoforms function in synaptic plasticity. In further support, synaptogyrin-
III and synapsin-III associated with PR-A and PR-B, respectively. PR also interacted with kinases, including c-Src,
mTOR, and MAPK1, confirming phosphorylation as an integral process in rapid effects of PR in the brain.
Consistent with a role in transcriptional regulation, PR associated with transcription factors and coactivators in a
ligand-specific and isoform-dependent manner. Interestingly, both PR isoforms associated with a key regulator
of energy homeostasis, FoxO1, suggesting a novel role for PR in energy metabolism. Because many identified
Significance Statement
Progesterone binds to the progestin receptor (PR) isoforms, PR-A and PR-B, in the brain to profoundly
influence female reproduction, brain development, neuroprotection, and stress. We combined mass
spectrometry and reverse phase protein arrays to identify mouse hypothalamic proteins that function in
synaptic plasticity, transcription, translation, and energy metabolism and interacted with PR in a ligand-
dependent and isoform-specific manner. In addition, progesterone increased synaptic density in primary
cortical neurons, suggesting a function for progesterone in synapse formation in cortical neurons. Taken
together, these findings provide evidence for novel functions of PR in synaptic modulation and energy
homeostasis to affect health and disease.
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proteins in this PR interactome are synaptic proteins, we tested the hypothesis that progestins function in
synaptic plasticity. Indeed, progesterone enhanced synaptic density, by increasing synapsin-I–positive synapses,
in rat primary cortical neuronal cultures. This novel combination of RPPA and mass spectrometry allowed
identification of PR action in synaptic remodeling and energy homeostasis and reveals unique roles for progestins
in brain function and disease.
Key words: Cortex; estrogen; progesterone; proteomics; synapse; synapsin
Introduction
Progestins, a class of steroid hormones, act in the brain
to profoundly influence development (Beyer et al., 2002;
Wagner, 2006); neuroprotection (Stein and Hoffman, 2003;
Singh, 2006; Irwin et al., 2008; Su et al., 2012); reproductive
behavior (Sinchak and Micevych, 2001; Blaustein, 2008);
learning, memory, and cognition (Hull et al., 1980; Sand-
strom and Williams, 2001; Wagner, 2006); and anxiety and
stress (Mora et al., 1996; Blaustein and Ismail, 2013; Keyes
et al., 2013; Uphouse et al., 2013). In addition, progestins
have been implicated in a variety of human diseases, includ-
ing neurodegeneration and breast cancer (Richer et al.,
2002; Brinton et al., 2008; Obr and Edwards, 2012; Diep
et al., 2015).
Progestins elicit many of their effects by binding to
progestin receptors (PR), which exist as two isoforms in
mammals, an N-terminally truncated PR-A and a full-
length PR-B (Tetel and Lange, 2009). Both isoforms share
a C-terminal ligand binding domain, a DNA binding do-
main, and two transactivation domains (Horwitz et al.,
1990; Kastner et al., 1990). Interestingly, a third transac-
tivation domain exclusive to PR-B, and a PR-A specific
inhibitory region, have been identified, allowing differ-
ential functions by the isoforms (Hovland et al., 1998).
Isoform-specific transcriptional activation by PR has
been observed in vitro and in vivo (Sartorius et al., 1994;
Giangrande et al., 1997; Conneely et al., 2000; Cheng
et al., 2001; Richer et al., 2002; Mulac-Jericevic et al.,
2003). Isoform-specific knockout mice reveal that al-
though PR-A in the mouse hypothalamus is the primary
mediator of female sexual behavior, both isoforms are
required for the full behavioral response (Mani et al.,
2006). In support, PR-A and PR-B are differentially
expressed in the female mouse hypothalamus (Acharya
et al., 2015).
PR associate with multiple proteins, including nuclear
receptor coactivators, which stabilize the receptor com-
plex and enhance transcription (Hill et al., 2012; Goswami
et al., 2014; Simons et al., 2014). In the female mouse
hypothalamus, the PR isoforms are differentially ex-
pressed with steroid receptor coactivator-1 (SRC-1, also
named NCOA1) and SRC-2 (NCOA2; Acharya et al.,
2015). In addition, SRC-1 and SRC-2 from hypothalamus
associate with the PR isoforms in a ligand-dependent and
isoform-specific manner (Molenda-Figueira et al., 2008;
Yore et al., 2010) and modulate hormone-dependent gene
expression and female sexual behavior (Apostolakis et al.,
2002; Molenda et al., 2002; Molenda-Figueira et al., 2006).
Taken together, these studies indicate that nuclear recep-
tor coactivators are important in PR function in the brain.
PR act through both classic and nonclassic pathways in
the brain and other progestin-responsive tissues. For ex-
ample, in the hypothalamus, PR activation induces lordo-
sis in female rodents through transcriptional regulation
(Leonhardt et al., 2003; Molenda-Figueira et al., 2006) as
well as nonclassic kinase activation (González-Flores
et al., 2004; Mani et al., 2006). PRs are present in syn-
apses (Waters et al., 2008; Mitterling et al., 2010) and
rapidly alter dendritic spine densities in rat hippocampus
(Woolley and McEwen, 1993; McEwen and Woolley,
1994), cortical neurons (Chen et al., 2009; Sanchez et al.,
2013), and hypothalamus (Griffin et al., 2010).
Although we are gaining a better understanding of dis-
tinct functions of the PR isoforms in brain, little is known
about the mechanisms involved. Therefore, to investigate
the factors that could contribute to the differential function
of the PR isoforms in brain, we have combined mass
spectrometry (MS) and reverse phase protein array
(RPPA) in a functional proteomic analysis to identify pro-
teins from adult female mouse hypothalamus that interact
with mouse PR-A and PR-B. In addition, given the iden-
tification of many synaptic proteins that interact with PR in
the present study, we tested the hypothesis that proges-
tins influence synaptic plasticity by increasing synapse
formation in cortical neurons.
Materials and Methods
Animals
Female C57/BL6 mice were bred in the Wellesley Col-
lege Animal Facility (Wellesley, MA). Mice were group-
housed (three to six/group) under a 12-h light/dark cycle.
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Food and water were available ad libitum. All animal
procedures were approved by the Institutional Animal
Care and Use Committee of Wellesley College and were
conducted in accordance with the National Institutes of
Health Guide for the Care and Use of Laboratory Animals.
Tissue collection and preparation
Mice (8 to 10 wks old) were bilaterally ovariectomized
under 1.5% isoflurane. One week later, mice were killed
by asphyxiation under CO2. Brains were quickly removed,
and hypothalamic tissue was dissected using coordinates
from the mouse brain atlas (Paxinos and Franklin, 2004),
immediately frozen on dry ice, and stored at –80°C until
homogenization. Hypothalami from four to eight mice
were pooled to generate each sample and lysed in lysis
buffer containing 10 mM Tris, 10% glycerol, 400 mM NaCl,
1 mM dithiothreitol (DTT), and 1 mM EDTA (pH 7.4) with
protease inhibitors (1:10 dilution, P2714, Sigma-Aldrich).
Lysates were incubated on ice for 30 min followed by
centrifugation at 13,200  g for 30 min at 4°C. Superna-
tants containing proteins were stored at –80°C.
Glutathione S-transferase–tagged mouse progestin
receptors
Mouse PR-B cDNA was cloned into the CMV-based
mammalian cell expression plasmid pcDNAI (Invitrogen)
by insertion into the PspHI/EcoRI site. Mouse PR-A cDNA
was prepared by partial digest of mouse PR-B cDNA,
ligated into the pBlueBacHis2B transfer plasmid, and in-
serted into the BamHI/EcoRV site of pcDNAI. pAcG2T
baculovirus expression vector (BD Biosciences) was used
for expression of PR-A and PR-B as fusion proteins,
containing an N-terminal glutathione S-transferase (GST) tag.
Site-directed mutations were performed using QuikChange XL
Site-directed Mutagenesis Kit (Stratagene). The mutated
sites were used to ligate cDNAs of mouse PR-A and PR-B
into the respective restriction sites of pAcG2T. Mouse
PR-A containing BamHI and EcoRI sites was ligated into
the respective sites of the mutated pAcG2T. Similarly,
mouse PR-B containing EcoRI and NotI sites was ligated
into the respective sites of the mutated pAcG2T. Both
DNA constructs were fully sequenced from the start of the
GST to the end of the mouse PR subtype (Genewiz).
After the full sequences were confirmed, recombinant
proteins containing full-length mouse PR-A or PR-B fused
to a GST tag were expressed in Spodoptera frugiperda
(Sf9) insect cells by the Baculovirus/Monoclonal Antibody
Facility of the Baylor College of Medicine as described
previously (Tetel et al., 1999; Molenda-Figueira et al.,
2008; Yore et al., 2010). Insect cell cultures for GST-PR
were incubated with saturating doses of 200 nM of the PR
agonist R5020 or in the absence of PR ligand. Sf9 cell
pellets were homogenized in buffer containing 10 mM Tris,
10% glycerol, 400 mM NaCl, 1 mM DTT, and 1 mM EDTA
(pH 7.4) with protease inhibitors. Homogenates were
incubated on ice for 30 min, and then centrifuged at
13,200  g for 30 min at 4°C. Supernatants containing
proteins were stored at – 80°C.
GST-PR pull-down
GST-PR pull-down assays were performed as de-
scribed previously (Molenda-Figueira et al., 2008; Yore
et al., 2010). Briefly, glutathione Sepharose 4B packed
resin (50 L, 0.05 mg/mL, GE Healthcare) was added to
siliconized centrifuge tubes and pretreated with ovalbu-
min (1 mg/mL, Thermo Fisher Scientific) for 15 min on an
end-over-end rotator at 4°C. Resin was rinsed three times
with TG buffer (20 mM Tris–HCl and 10% glycerol) con-
taining 1 M urea and 100 mM NaCl (TG-NaCl-U, pH 8.0).
GST-PRA or GST-PRB bound to the agonist R5020, or
unliganded, were used for pull-downs. R5020 is a syn-
thetic progestin that binds with a similar affinity to both
PR-A and PR-B (Skafar, 1991; Carbajo et al., 1996). Equal
amounts of recombinant mouse GST-PR suspended in
TG buffer with 1 M urea (TG-U, pH 8.0) were added to
resin and incubated on a rotator at 4°C for 1 h. After
incubation, resin with immobilized GST-PR was washed
four times with TG-NaCl-U (with reducing urea concen-
trations of 1, 0.5, 0.25, and 0 M). Equal amounts of pooled
hypothalamic homogenates were added to immobilized
GST-PR and incubated on a rotator for 1 h at 4°C. The
resins were washed four times with TG-NaCl (without
urea).
Proteins bound to GST-PR resin were eluted in specific
buffers for each of the analyses. For Western blots, sam-
ples were eluted by boiling for 5 min in 2 Laemmli
sample buffer (Bio-Rad) with 35 mM DTT (Sigma-Aldrich)
for 5 min. For MS analysis, GST-PR and proteins bound to
resin were eluted by incubating in 250 mM glutathione
elution buffer (in 50 mM Tris-HCl, pH 8.0) at 4°C for 10 min.
Samples for RPPA analysis were boiled in SDS sample
buffer (Invitrogen) with 2.5% -mercaptoethanol for 5 min.
Mass spectrometry analysis
Pull-down assays for MS were performed with GST-
PRA or GST-PRB, unliganded or bound to R5020. Tryptic
peptides prepared as previously described (Molenda-
Figueira et al., 2008) for each receptor type and ligand
condition were block-randomized and analyzed in tripli-
cate (Oberg and Vitek, 2009) by nano-LC-MS/MS using a
nano-LC chromatography system (UltiMate 3000 RSLCnano,
Dionex), coupled online to a Thermo Orbitrap Fusion mass
spectrometer (Thermo Fisher Scientific) through a nano-
spray ion source (Thermo Fisher Scientific). Chromato-
graphic columns were made from 75-m-ID polyimide-
coated fused silica capillary (Polymicro Technologies)
packed with 5 m Zorbax SB-C18 reversed-phase pack-
ing (Agilent) to a length of 10 cm by using a Pressure
Injection Cell (NextAdvance). The trap column was pre-
pared in the same manner but to a length of 1 cm. After
equilibrating the column in 98% solvent A (0.1% formic
acid in water) and 2% solvent B (0.1% formic acid in
acetonitrile), the samples (3 L in solvent A) were injected
onto the trap column and eluted (400 nL/min) by gradient
elution onto the C18 column as follows: isocratic at 2% B,
0–5 min; 2% to 32% B, 5–49 min; 32% to 90% B, 49–50
min; isocratic at 90% B, 50–54.5 min; 90% to 2% B,
54.5–55 min; and isocratic at 2% B, 55–60 min. All LC-
MS/MS data were acquired using XCalibur, version 2.1.0
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(Thermo Fisher Scientific) in positive ion mode using a top
speed data-dependent acquisition method with a 2-s cy-
cle time. The survey scans (m/z 350–1600) were acquired
in the Orbitrap at 120,000 resolution (at m/z 400) in profile
mode, with a maximum injection time of 50 ms and an
automatic gain control (AGC) target of 400,000 ions. The
S-lens RF level was set to 60. Isolation was performed in
the quadrupole with a 1.6-Da isolation window, and CID
MS/MS acquisition was performed in profile mode in the
ion trap using rapid scan rate, with the following settings:
parent threshold, 10,000; isolation width, 1.6 Da; normal-
ized collision energy, 35%; maximum injection time, 150
ms; and AGC target, 10,000 ions. Monoisotopic precursor
selection and charge state filtering were on, with charge
states 2–4 included. Dynamic exclusion was used to
remove selected precursor ions for 60 s after acquisition
of one MS/MS spectrum.
Proteomic data analysis of MS samples
All data files were searched against a Uniprot mouse
database (June 2014 version, 16,728 proteins), appended
with the Common Repository of Adventitious Proteins
contaminant database using PEAKS (Ma et al., 2003; Han
et al., 2004, 2011; Zhang et al., 2012). Searches were
performed with a parent ion tolerance of 10 ppm, frag-
ment ion tolerance of 0.80 Da, fixed modification of car-
bamidomethyl (C), and variable modifications of oxidation
(M) and phosphorylation (STY). Trypsin was specified as
the enzyme, allowing for two missed cleavages and
one nonspecific cleavage. False discovery rate (FDR) es-
timation was allowed. The resulting peptide-spectrum
matches 1% FDR were used to generate a spectral
library for subsequent quantitative analysis. Data files for
each pair of samples were imported into Skyline (Ma-
cLean et al., 2010) for label-free quantitative analysis
(Schilling et al., 2012). After manual verification of all
peaks, triplicate peptide intensities were used to calculate
fold changes and p-values.
Reverse phase protein array analysis
Hypothalamic tissue from adult female mice (n  32)
was pooled into four different groups. Similar to MS,
RPPA assays were performed using pull-downs with
GST-PRA and GST-PRB bound to R5020 or unliganded.
RPPA assays were conducted as described previously
(Chang et al., 2015) with the following modifications. Pro-
teins associating with GST-PR bound to resins were
eluted in 2 Tris-glycine SDS buffer with 2.5% -merca-
ptoethanol and mixed with modified Tissue Protein Ex-
traction Reagent (Pierce and Xu, 2010) and a cocktail of
protease and phosphatase inhibitors (Roche Life Science;
Chang et al., 2015). A 2470 Arrayer (Aushon BioSystems)
with a 40-pin (185 m) configuration was used to spot
samples and control lysates onto nitrocellulose-coated
slides (Grace Bio-labs) using an array format of 960 ly-
sates/slide (2880 spots/slide). The slides were processed
as described previously (Chang et al., 2015) and probed
with a set of 212 antibodies (Table 1) against 140 total
proteins and 72 proteins phosphorylated on specific sites
using an automated slide stainer, Autolink 48 (Dako). Each
slide was incubated with one specific primary antibody.
Negative control slides were incubated with antibody di-
luent instead of primary antibody. Primary antibody bind-
ing was detected using a biotinylated secondary antibody
followed by streptavidin-conjugated IRDye680 fluoro-
phore (LI-COR Biosciences). The total protein content of
each spotted lysate was assessed by fluorescent staining
with Sypro Ruby Protein Blot Stain according to the man-
ufacturer’s instructions (Invitrogen).
Fluorescence-labeled slides were scanned on a Ge-
nePix 4400 AL scanner. Each slide, along with its ac-
companying negative control slide, was scanned at an
appropriate photomultiplier tube to obtain optimal signal
for this specific set of samples. The images were analyzed
with GenePix Pro 7.0 (Molecular Devices). Total fluores-
cence signal intensities for each spot were obtained after
subtraction of the local background signal for each slide
and were then normalized for variation in total protein,
background, and nonspecific labeling using a group-
based normalization method as described (Chang et al.,
2015). Each image, along with its normalized data, was
evaluated for quality through manual inspection and com-
parison with control samples. Specific fluorescence inten-
sity signals of 50 units or less was taken as assay cutoff
for a positive reaction, resulting in 195 remaining proteins,
of the 212 (Table 1), to be analyzed.
Analysis of data from RPPA assays
After data were normalized to PR signal in the assay or
to target protein input, it was determined that normalizing
to PR produced the most consistent results. The effects of
receptor type and hormone treatment were analyzed via
two-way ANOVA using R. We identified proteins with
FDR-adjusted p-values 0.05. For this subset of identi-
fied proteins, relative fold changes between the liganded
and unliganded receptor were calculated for each iso-
form. For proteins displaying a positive interaction with
the liganded PR, a two-fold change was used as a cutoff.
For proteins showing a positive association with the unli-
ganded PR, further stringency was maintained by setting
a higher threshold of three-fold change, as with the MS
data.
Western blot analysis
Western blot analyses were performed on representa-
tive proteins: synapsin-I and synapsin-II (MS-identified)
and SRC-1, SRC-2, FoxO1, MED12, c-Fos, and c-Jun
(RPPA-identified) to validate findings from the MS and
RPPA analyses. Western blots were conducted as de-
scribed previously (Bless et al., 2014) with the modifica-
tions indicated below. For independent validation of the
ligand-dependent interaction of PR with hypothalamic
SRC-1 and SRC-2 determined by RPPA, protein homog-
enates from female mouse hypothalamus (n  6, 5 mice
per group) were prepared as described above. Pull-down
samples were probed for SRC-1 and SRC-2 using a rabbit
polyclonal antibody to 350–690 amino acids (aa) of human
SRC-1 (1:250, #sc-8995, Santa Cruz, RRID:AB_2235896) and
a rabbit polyclonal antibody to human SRC-2 (1:750, #PA1-
86392, Fisher Scientific, RRID:AB_2103955), respectively.
MED12, c-Fos and c-Jun were probed with rabbit poly-
clonal antibodies MED12 (1:200, #ab70842, Abcam),
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Table 1. List of antibodies used for RPPA analysis
Antibody name Company Catalog # Host
14-3-3zeta,gamma,eta_R_V EMD Millipore (Upstate) 06-408 Rabbit
Akt_R_V CST 9272 Rabbit
p-Akt(S473)_R_V CST 9271 Rabbit
p-Akt(T308)_R_V CST 9275 Rabbit
p-ALK(3B4)(Y1586)_R_V CST 3348 Rabbit
p-ALK(Y1604)_R_V CST 3341 Rabbit
p-AMPKa(40H9)(T172)_R_V CST 2535 Rabbit
p-AMPKa1(S485)_R_V CST 4184 Rabbit
p-AMPKb1(S108)_R_V CST 4181 Rabbit
Annexin1_R_V Invitrogen 71-3400 Rabbit
ATM_R_V Abcam ab32420 Rabbit
ATR_R_V CST 2790 Rabbit
p-ATR(S428)_R_V CST 2853 Rabbit
p-AuroraA(T288)/B(T232)/C(T198)_R_V CST 2914 Rabbit
AuroraA/AIK_R_V CST 3092 Rabbit
p-Axl(D12B2)(Y702)_R_V CST 5724 Rabbit
Bad_R_V CST 9292 Rabbit
p-Bad(S112)_R_V CST 9291 Rabbit
p-Bad(S136)_R_V CST 9295 Rabbit
p-Bad(S155)_R_V CST 9297 Rabbit
Bak_R_V CST 3814 Rabbit
Bax_R_V CST 2772 Rabbit
p-Bcl2(5H2)(S70)_R_V CST 2827 Rabbit
p-Bcl2(T56)_R_V CST 2875 Rabbit
BRCA1_R_V EMD Millipore (Upstate) 07-434 Rabbit
BRCA2_R_V CST 9012 Rabbit
Caspase-3_R_V CST 9662 Rabbit
p-Beta-Catenin(S33/37/T41)_R_V CST 9561 Rabbit
Caveolin-1(D46G3)XP_R_V CST 3267 Rabbit
p-Caveolin-1(EPR2288Y)(Y14)_R_V Abcam-Epitomics 2267-1 Rabbit
CD24(FL-80)_R_V Santa Cruz Biotechnology sc-11406 Rabbit
p-Chk1(S345)_R_V CST 2341 Rabbit
p-Chk2(S33/35)_R_V CST 2665 Rabbit
Claudin-1_R_V CST 4933 Rabbit
c-Met_R_V Abcam ab51067 Rabbit
p-c-Myc(T58)_R_V Abcam ab28842 Rabbit
DKK1_R_V CST 4687 Rabbit
EGFR(D38B1)XP_R_V CST 4267 Rabbit
EGFR(L858R)_R_V CST 3197 Rabbit
p-EGFR(S1046/1047)_R_V CST 2238 Rabbit
p-EGFR(Y1045)_R_V CST 2237 Rabbit
p-EGFR(Y1148)_R_V CST 4404 Rabbit
p-EGFR(Y1173)_R_V Invitrogen (BioSource) 44-794G Rabbit
p-EGFR(Y1173)(53A5)_R_V CST 4407 Rabbit
p-EGFR(Y1068)(D7A5)XP_R_V CST 3777 Rabbit
Ezh2(D2C9)XP_R_V CST 5246 Rabbit
FGFR1(D8E4)XP_R_V CST 9740 Rabbit
FoxO1(C29H4)_R_V CST 2880 Rabbit
FSP1/S100A4_R_V EMD Millipore Jul-74 Rabbit
p-HER2/ErbB2(Y1248)_R_V CST 2247 Rabbit
p-HER2/ErbB2(Y877)_R_V Imgenex IMG-90185 Rabbit
HER3/ErbB3_R_V CST 4754 Rabbit
p-HER3/ErbB3(Y1197)_R_V CST 4561 Rabbit
HDAC1_R_V CST 2062 Rabbit
HDAC3_R_V CST 2632 Rabbit
HDAC4_R_V CST 2072 Rabbit
HDAC6_R_V Santa Cruz Biotechnology sc-11420 Rabbit
ILK1_R_V CST 3862 Rabbit
p-Jak1(Y1022/1023)_R_V CST 3331 Rabbit
Kit-c_R_V Abcam ab32363 Rabbit
Lipocalin-1_R_V Santa Cruz Biotechnology sc-66943 Rabbit
(Continued)
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Table 1. Continued
Antibody name Company Catalog # Host
LRP6_R_V CST 2560 Rabbit
MEK1_R_V Abcam-Epitomics 1235-1 Rabbit
p-MEK1/2(S217/221)_R_V CST 9121 Rabbit
p-Met(Y1234/1235)_R_V CST 3077 Rabbit
MMP-9_R_V CST 3852 Rabbit
mTOR_R_V CST 2972 Rabbit
p-mTOR(D9C2)XP(S2448)_R_V CST 5536 Rabbit
Notch1(C44H11)_R_V CST 3268 Rabbit
p-p27(T187)_R_V Invitrogen (Zymed) 71-7700 Rabbit
p-p27/KIP1(T198)_R_V Abcam ab64949 Rabbit
p27/KIP1(C-term)_R_V Abcam-Epitomics ab32034(1591-1) Rabbit
p38/MAPK_R_V CST 9212 Rabbit
p-p38(D3F9) XP(T180/Y182)_R_V CST 4511 Rabbit
p44/42MAPK(Erk1/2)_R_V CST 9102 Rabbit
p-p44/42MAPK(Erk1/2)(T202/Y204)(197G2)_R_V CST 4377 Rabbit
p53_R_V CST 9282 Rabbit
p-p53(S15)_R_V CST 9284 Rabbit
p70S6K_R_V CST 9202 Rabbit
p-p70S6K(S371)_R_V CST 9208 Rabbit
p-p70S6K(T389)_R_V CST 9205 Rabbit
p-p70S6K(T412)_R_V EMD Millipore (Upstate) 07-018 Rabbit
p-PDGFRa(23B2)(Y754)_R_V CST 2992 Rabbit
PDGFRb(28E1)_R_V CST 3169 Rabbit
p-PDK1(S241)_R_V CST 3061 Rabbit
PIAS1_R_V CST 3550 Rabbit
PTEN(D4.3)XP_R_V CST 9188 Rabbit
p-PTEN(S380)_R_V CST 9551 Rabbit
p-RafB(S445)_R_V CST 2696 Rabbit
RANKL_R_V Novus NBP1-31140 Rabbit
p-Ret(Y905)_R_V CST 3221 Rabbit
Slug(C19G7)_R_V CST 9585 Rabbit
p-Smad2(S465/467)_R_V CST 3101 Rabbit
SOCS1(A156)_R_V CST 3950 Rabbit
SOCS3_R_V CST 2923 Rabbit
Sox2(D6D9) XP_R_V CST 3579 Rabbit
p-Src(Y527)_R_V CST 2105 Rabbit
Stat1_R_V CST 9172 Rabbit
p-Stat1(Y701)_R_V CST 9171 Rabbit
p-Stat2(Y690)_R_V CST 4441 Rabbit
p-Stat3(S727)_R_V CST 9134 Rabbit
p-Stat4(Y693)_R_V CST 5267 Rabbit
p-Stat5(Y694)_R_V CST 9351 Rabbit
Stat6_R_V CST 9362 Rabbit
p-Stat6(Y641)_R_V CST 9361 Rabbit
p-Tuberin/TSC2(T1462)_R_V CST 3611 Rabbit
Vimentin(D21H3)XP_R_V CST 5741 Rabbit
Wnt5a/b(C27E8)_R_V CST 2530 Rabbit
YAP(H125)_R_V Santa Cruz Biotechnology sc-15407 Rabbit
ZO-1_R_V CST 5406 Rabbit
Caspase-7_R_V CST 9491 Rabbit
VEGFR2(55B11)_R_V CST 2479 Rabbit
Stat5a(L-20)_R_V Santa Cruz Biotechnology sc-1081 Rabbit
SOX9_R_V EMD Millipore (Upstate) AB5535 Rabbit
p-SAPK/JNK(T183/Y185)_R_V CST 4668 Rabbit
Zeb1_R_V Novus NBP1-05987 Rabbit
PHF8(pAb)_R_V Active Motif 39711 Rabbit
ASH2_R_V Bethyl Laboratories A300-489A Rabbit
CBP(A-22)_R_V Santa Cruz Biotechnology sc-369 Rabbit
c-Fos(9F6) _R_V CST 2250 Rabbit
CHAF1A(D77D5)XP_R_V CST 5480 Rabbit
c-Jun(60A8)_R_V CST 9165 Rabbit
CRSP1-TRAP220_R_V Bethyl Laboratories A300-793A Rabbit
(Continued)
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Table 1. Continued
Antibody name Company Catalog # Host
CtBP2_R_V CST 13256 Rabbit
Cyclin C_R_V Santa Cruz Biotechnology sc-1061 Rabbit
DRIP130_R_V Abcam ab70450 Rabbit
FBX011_R_V Abcam ab72200 Rabbit
FoxK2_R_V CST 12008 Rabbit
KLF4_R_V CST 12173 Rabbit
MED12-Abcam_R_V Abcam ab70842 Rabbit
p300(C-20)_R_V Santa Cruz Biotechnology sc-585 Rabbit
p-c-Fos(S32)_R_V CST 5348 Rabbit
PPP1R10(EPR11706)_R_V Abcam ab173285 Rabbit
Stat3(D3Z2G)_R_V CST 12640 Rabbit
p-TRAP220-MED1(T1457)_R_V Abcam ab60950 Rabbit
HIF-2A(D9E3)_R_V CST 7096 Rabbit
p-c-Jun(S63)_R_V CST 9261 Rabbit
Sin3b_R_V Abcam ab101841 Rabbit
p-Rb(S807/811)_R_V CST 9308 Rabbit
p-Rb(S780)(C84F6)_R_V CST 3590 Rabbit
p-FAK(Y576/577)_R_V CST 3281 Rabbit
Ki67_R_V Vector Laboratories VP-K451 Rabbit
Integrina4(D2E1)XP_R_V CST 8440 Rabbit
Integrina5_R_V CST 4705 Rabbit
IntegrinaV_R_V CST 4711 Rabbit
Integrinb1(D2E5)_R_V CST 9699 Rabbit
Integrinb3(D7X3P)XP_R_V CST 13166 Rabbit
Integrinb4_R_V CST 4707 Rabbit
PI3Kp85_R_V CST 4292 Rabbit
AMPKa(23A3)_R_V CST 2603 Rabbit
PI3Kp110a(C73F8)_R_V CST 4249 Rabbit
ERa(SP1)_R_V Thermo Fisher Scientific RM-9101-S1 Rabbit
MEK6_R_V Abcam ab52937 Rabbit
p21_R_V CST 2947 Rabbit
Atg12(D88H11)_R_V CST 4180 Rabbit
Beclin-1(D40C5)_R_V CST 3495 Rabbit
Caspase-3(Asp175)_R_V CST 9661 Rabbit
Beta-Catenin(CT)_R_V Invitrogen 71-2700 Rabbit
Atg3_R_V CST 3415 Rabbit
Atg7_R_V CST 8558 Rabbit
LC3A(D50G8)XP_R_V CST 4599 Rabbit
LC3B(D11)XP_R_V CST 3868 Rabbit
p-EGFR(Y845)_R_V CST 2231 Rabbit
p-EGFR(Y992)_R_V CST 2235 Rabbit
ErbB2/HER2(Y1248)_R_V Imgenex IMG-90189 Rabbit
p-SHC(2431)(Y317)_R_V CST 2431 Rabbit
SRD5A1_R_V Novusbio H00006715-D01P Rabbit
FAS_R_V CST 3189 Rabbit
HexokinaseII(C64G5)_R_V CST 2867 Rabbit
PFKFB3 (C-terminal)_R_V Abcam ab135820 Rabbit
RRM2 (EPR11820)_R_V Abcam ab172476 Rabbit
p-Stat1(Y701)(D4A7)_R_V CST 7649 Rabbit
GLDC_R_V CST 12794 Rabbit
GLS1_R_V Proteintech 20170-1-AP Rabbit
LDHA_R_V CST 2012 Rabbit
PHGDH_R_V CST 13428 Rabbit
PKM2_R_V Bethyl Laboratories A303-660A-M Rabbit
PKM1/2_R_V CST 3190 Rabbit
Bcl-xL_R_V CST 2762 Rabbit
E-Cadherin(24E10)_R_V CST 3195 Rabbit
ALK(D5F3)XP_R_V CST 3633 Rabbit
HER2/c-ErbB2_R_V Dako A0485 Rabbit
ALDH_M_V BD Biosciences 611194 Mouse
p-ATM(S1981)_M_V CST 4526 Mouse
Axl_M_V Abcam ab54803 Mouse
(Continued)
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c-Fos (1:200, #5348, Cell Signaling Technology), and
c-Jun (1:200, #9261, Cell Signaling Technology), respec-
tively. Fluorescently labeled donkey anti-goat AF488 and
donkey anti-rabbit AF647 were used for detection of
SRC-1 and SRC-2 (1:10,000, Invitrogen), respectively.
Immunoreactive bands were detected and relative op-
tical densities were quantified using a GelDoc Imager
and Image Lab Software (Bio-Rad). Two-way ANOVA fol-
lowed by Tukey’s honestly significant difference was used
(SPSS v.21) to examine the effect of ligand and receptor
type. We identified differences with Tukey-adjusted
p-values 0.05. In addition, validation of MS findings of
synapsin-I and synapsin-II by Western blot was con-
ducted using a rabbit polyclonal antibody to synapsin-I
(1:500, #ab1543, Millipore, RRID:AB_2200400) and a
mouse monoclonal antibody to synapsin-II (0.3g/mL,
#mabn1573, Millipore). Secondary antibodies donkey
anti-rabbit AF647 and donkey anti-mouse AF488 (1:10,000,
Invitrogen) were used for synapsin-I and synapsin-II, respec-
tively.
In confirmation of findings by RPPA, interaction of PR
with FoxO1 was analyzed by Western blot using a rabbit
polyclonal FoxO1 antibody (1:250, #2880, CST, RRID:
AB_2106495), the same as used for RPPA, followed by a
donkey anti-rabbit AF647 secondary antibody (1:10,000,
Invitrogen). For the detection of mouse GST-PR, a mouse
monoclonal antibody directed against the N-terminal 165–
534 aa of human PR-A and PR-B (PR 1294, 0.5 g/mL),
followed by a donkey anti-mouse AF488 secondary anti-
body (1:10,000, Invitrogen), was used.
Neuronal cultures
Primary cortical neuronal cultures (mixed sex) were
prepared from Sprague-Dawley rat E18 embryos as de-
scribed previously (Srivastava et al., 2011). These cortical
cultures display mature neuronal morphology (extensive
arborizations and dendritic spines) and electrophysiolog-
ical and cellular responses to synaptic activity, consistent
with those seen in in vivo/ex vivo studies of mature neu-
rons (Xie et al., 2007; Srivastava et al., 2012). Because our
MS and RPPA data were collected from mature brain,
cortical neurons, which recapitulate mature neuronal
characteristics (Xie et al., 2007; Srivastava et al., 2012),
were used in these studies.
Animals were habituated for 3 d before experimental
procedures, compliant with the Home Office Animals (Sci-
entific Procedures) Act, UK, 1986. Dissociated cells were
plated onto 18-mm glass coverslips (no. 1.5; 0117580,
Marienfeld-Superior), coated with poly-D-lysine (0.2 mg/
ml, Sigma-Aldrich), at a density of 3  105/well equal to
857/mm2 and cultured in feeding medium: neurobasal
medium (21103049) supplemented with 2% B27 (17504044),
0.5 mM glutamine (25030024), and 1% penicillin:strepto-
mycin (15070063; all reagents from Invitrogen). Neuron
cultures were maintained in the presence of 200 M D,L-
amino-phosphonovalerate (D,L-APV, ab120004, Abcam)
beginning on 4 d in vitro (DIV 4) to maintain neuronal
health for long-term culturing and reduce cell death due to
excessive Ca2 cytotoxicity via overactive NMDA recep-
tors (Srivastava et al., 2011). Half-medium changes were
performed twice weekly until the desired age (DIV 23–25).
Table 1. Continued
Antibody name Company Catalog # Host
CD24 Ab2(SN3b)_M_V Thermo Fisher Scientific MS-1279-P0 Mouse
Chk2(1C12)_M_V CST 3440 Mouse
Cox-2_M_V BD Biosciences 610203 Mouse
GATA3_M_V BD Biosciences 558686 Mouse
GSK-3a/b_M_V Santa Cruz Biotechnology SC-7291 Mouse
HER2/c-ErbB2-P185_M_V Invitrogen (BioSource) AHO1011 Mouse
HIF-1a_M_V BD Biosciences 610958 Mouse
p-IkappaB-a(S32/36)_M_V BD Biosciences 551818 Mouse
S100A7/CBP_M_V Abnova H00006278-A01 Mouse
Twist(Twist2C1a)_M_V Santa Cruz Biotechnology sc-81417 Mouse
SRC-3(clone 1208/D1)_M_V BCM-Mab in house Mouse
c-Myc(clone 1123)_M_V BCM-Mab in house Mouse
SRC-2(TIF2)_M_V BD 610985 Mouse
SRC-1(clone 1135/H4,1136/H4H6)_M_V BCM-Mab in house Mouse
PR(1294)_M_V Celetta in house_Celetta Mouse
Rb(4H1)_M_V CST 9309 Mouse
p-FAK(Y397)_M_V BD Biosciences 611806 Mouse
AR-441_M_V BCM NW-Mab70 Mouse
AMPKa(F6)_M_V CST 2793 Mouse
Bcl2(Clone-124)_M_V Dako M088729-2 Mouse
c-Src(B-12)_M_V Santa Cruz Biotechnology sc-8056 Mouse
IGF-IR(3B7)_M_V Santa Cruz Biotechnology sc-462 Mouse
Laminin5_M_V EMD Millipore MAB19562 Mouse
Aromatase-A(Clone 677H7F10)_M_V BCM-Mab in house Mouse
AOX1(cloneAO15)_M_V Sigma-Aldrich SAB4200562 Mouse
IDH2_M_V Abcam ab55271 Mouse
SCD1 (CD.E10)_M_V Abcam ab19862 Mouse
Host species for the antibodies and validation status are reported. R, rabbit; M, mouse and V, validated.
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Pharmacological treatment of neuronal cultures
All pharmacological treatments were performed on DIV
25–30 primary cortical neuronal cultures. Treatments
were conducted in feeding medium: neurobasal medium
(21103049) supplemented with 2% B27, 0.5 mM glu-
tamine, and 1% penicillin:streptomycin in the presence of
200 M D,L-APV. Progesterone (P4; Sigma-Aldrich, P6149)
was dissolved in ethanol to a concentration of 31.8 mM,
and 17-estradiol (E2) was dissolved in dimethylsulfoxide
to a final concentration of 1 mM. Both compounds were
serially diluted to a 10 working concentration in feeding
medium and applied directly to neuronal cultures. Final
concentrations of P4 and E2 were 1 nM. Final concentra-
tion of solvent was 0.01%: vehicle control was made up
of solvent lacking compound, diluted as test compounds.
Neuronal cultures were treated for 24 h, washed in PBS,
and fixed in 4% formaldehyde/4% sucrose PBS for 10
min at room temperature followed by incubation in meth-
anol prechilled to –20°C for 10 min at 4°C. Fixed neuronal
cultures were then permeabilized and blocked simultane-
ously (2% normal goat serum, 5425S, Sigma-Aldrich, and
0.2% Triton X-100) before incubation with the following
primary antibodies overnight: PSD95 mouse monoclonal
antibody (1:1000; clone K28/43; #73-028, NeuroMab,
RRID:AB_10698024), synapsin-I rabbit polyclonal anti-
body (1:200; #5297, Cell Signaling Technologies), and
MAP2 chicken polyclonal antibody (1:2000; #AB104896,
Abcam). Cultures were subsequently incubated with Al-
exa Fluor anti-rabbit 488, anti-mouse 568, and anti-
chicken 633 secondary antibodies (1:750; Invitrogen) the
following day for 1 h at room temperature (Srivastava
et al., 2011).
Quantitative and statistical analysis of
immunofluorescence
Confocal images of neurons were acquired with a Nikon
A1-R confocal microscope using a 60 oil-immersion
objective (NA 1.4; Nikon) as a z-series, z-step set to 0.5
m. Two-dimensional maximum-projection reconstruc-
tions of images were generated, and morphometric anal-
ysis (puncta number and intensity) was conducted using
MetaMorph software (Universal Imaging Corporation;
Srivastava et al., 2011). Analyses of puncta were per-
formed on spines from at least two dendrites (secondary
or tertiary branches), totaling 100 m, from each neuron.
The linear density of each synaptic protein cluster was
measured automatically using MetaMorph (Srivastava
et al., 2011). Synaptic puncta were defined as synapsin-I
puncta that contained PSD95 immunofluorescence
greater than background; background fluorescence was
the average background intensity from five regions of
interest plus two standard deviations (Glynn and McAllis-
ter, 2006). Cultures that were directly compared were
stained simultaneously and imaged with the same acqui-
sition parameters. For each condition, 10–16 neurons
from at least 3 separate experiments were used. Experi-
ments were conducted blind to condition and on sister
cultures.
All statistical analyses were performed in GraphPad.
Differences in quantitative immunofluorescence were
identified by a one-way ANOVA with Tukey correction for
multiple comparisons. Error bars represent the standard
error of the mean.
Results
Mass spectrometry
To detect proteins from female mouse hypothalamus
that associated with mouse PR in the presence or ab-
sence of hormone, MS analysis was performed on pull-
down samples using GST-tagged PR. This unbiased
approach identified many hypothalamic proteins that in-
teract with one or both PR isoforms in a ligand-dependent
manner (Tables 2 and 2-1). MS-identified proteins were
categorized into the following groups based on their
functions: (a) synaptic structure and function, (b) signal
transduction, (c) transcription, (d) translation, and (e) me-
tabolism. The proteins associated with synaptic structure
and function was the largest group, containing 61% (20 of
35) of the MS-identified proteins that interacted with
ligand-bound PR. Subsets of these synaptic proteins as-
sociated with PR-A only (9 proteins), PR-B only (7), or
both isoforms (4) in a ligand-dependent manner, strongly
indicating a function for both PR isoforms in synaptic
physiology. More than 18% (6 of 35) of the identified
PR-interacting proteins are transcriptional regulators, with
two-thirds associating with PR-B only and the remaining
one-third associating with PR-A only. Proteins involved in
signal transduction, including kinases, comprised 9% (3
of 35) of the MS-identified proteins that associated with
PR in the presence of ligand. We also identified the trans-
lational regulators 40S ribosomal protein S9 and 26S
protease regulatory subunit 6A that associated only with
PR-B in the presence of R5020. On the other hand, pro-
teins with a role in cellular metabolism identified by MS
interacted with liganded PR-A only (Table 2). Finally, con-
sistent with previous studies (Bagchi et al., 1991; Johnson
and Toft, 1994), a large number of additional proteins
interacted with unliganded PR-A, PR-B, or both
(Table 2-1).
To validate findings by MS, pull-down samples were
analyzed by Western blot for select synaptic proteins, the
largest functional group identified in the MS analysis.
Western blot results showed an increased interaction of
synapsin-Ia and synapsin-Ib with both PR-A and PR-B in
the presence of R5020 compared with no ligand (Fig. 1).
Similarly, the synapsin-II isoforms, synapsin-IIa and
synapsin-IIb, interacted with PR-A and PR-B in a ligand-
dependent manner, further extending the MS findings.
RPPA
To further explore the interactions of proteins from
mouse hypothalamus with PR, we used RPPA, which
provides a targeted approach and allows identification of
phospho-proteins as markers of protein activity. RPPA
analysis identified multiple proteins that interacted with
mouse PR in a ligand-dependent and isoform-specific
manner (Tables 3 and 3-1). In support of the present MS
results, many of the identified proteins that associated
with liganded PR were transcriptional regulators (Table 3).
Additional proteins identified by RPPA that were not de-
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tected by MS have known roles in signal transduction or
metabolism; a subset were phosphorylated forms of sig-
naling proteins, including src kinase (Table 3).
Two nuclear receptor coactivators, SRC-1 and SRC-2,
known to be involved in PR expression and function in
brain (Molenda et al., 2002; Molenda-Figueira et al., 2006,
2008; Yore et al., 2010; Acharya et al., 2015), were also
detected by RPPA to interact with PR-A and PR-B in the
presence of R5020 compared with no ligand. Ligand-
dependent interactions with SRC-1 and SRC-2 were fur-
ther confirmed by Western blot analysis (Fig. 2). Two-way
ANOVA on SRC-1 relative intensity showed an effect of
ligand (F  14.56, p  10.0  10–4) such that SRC-1
interacted with PR-A and PR-B in the presence of R5020
compared with no ligand. Similarly, SRC-2 associated
with both PR isoforms when bound to R5020 (F  21.65,
p  3.0  10–5) compared with no ligand. There were
differences between receptor subtypes on interaction
with either SRC-1 or SRC-2 (Fig. 2). Interestingly, the
majority of proteins that function as transcriptional regu-
lators, as identified by RPPA, interacted with PR-A only
(Table 3). Furthermore, proteins involved in signal trans-
duction identified by RPPA interacted with PR-A, but not
PR-B, in the presence of agonist (Table 3). A transcription
factor with a role in energy metabolism, FoxO1, was also
identified to interact with both PR-A and PR-B. This in-
teraction of FoxO1 with PR was further validated by West-
ern blot (Fig. 3). Confirmation of c-Fos, c-Jun, and
MED12, identified by RPPA, by Western blot was not
possible because the signal intensities of these proteins
by Western were not strong enough to be analyzed, most
likely because of the decreased sensitivity of Western blot
compared with RPPA. Two other proteins identified by
MS to interact with liganded PR, MAP kinase 1 and 14-3-3
protein /, were not found to associate with PR in a
ligand-dependent manner by RPPA, likely because of
differences in sensitivities for specific proteins between
the two techniques.
Table 2. Proteins from mouse hypothalamus, identified by MS analysis, associate with mouse PR in a ligand-dependent
manner




Synapsin-I SYN1 O88935  
Synapsin-II SYN2 Q64332  
Synapsin-III SYN3 Q8JZP2 
Synaptogyrin-III SNG3 Q8R191 
-Synuclein SYUA O55042 
Septin-5 SEPTM5 Q9Z2Q6 
Desmoglein-4 Desmoglein-4 Q7TMD7 
Desmoplakin DESP E9Q557 
Junction plakoglobin PLAK Q02257 
Leucine-rich repeat-containing protein 15 LGR4 A2ARI4 
Hemoglobin subunit -1 HBB1 P02088 
-Actin-like protein 2 ACTBL Q8BFZ3 
Tubulin -1A chain TBA1A P68369 
Tubulin -1B chain TBA1B P05213 
Tubulin -2A chain TBB2A Q7TMM9  
Tubulin -3 chain TBB3 Q9ERD7 
Tubulin -4A chain TBB4A Q9D6F9 
Tubulin -4B chain TBB4B P68372 
Tubulin -5 chain TBB5 P99024  
Tubulin -6 chain TBB6 Q922F4 
Signal transduction
Mitogen-activated protein kinase 1 MK01 P63085 
14-3-3 protein / 1433Z P63101 
Rab GDP dissociation inhibitor  GDIB Q61598 
Transcription
Elongation factor 1 TIF1B Q62318 
Histone H4 H4 P62806 
Brain acid soluble protein 1 A4 P12023 
Heterogeneous nuclear ribonucleoprotein D-like HNRDL Q9Z130 
Heterogeneous nuclear ribonucleoprotein U-like protein 1 HNRL1 Q8VDM6 
Probable ATP-dependent RNA helicase DDX5 DDX5 Q61656 
Translation
26S protease regulatory subunit 6A PRS6A O88685 
40S ribosomal protein S9 RS9 Q6ZWN5 
Metabolism
Creatine kinase B-type KCRB Q04447 
Phytanoyl-CoA hydroxylase-interacting protein-like PHIPL Q8BGT8 
Proteins associate with PR with R5020/no ligand at a ratio 2 and p  0.05. Table 2-1 shows proteins identified by MS that associate with PR in the ab-
sence of ligand.
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Similar to the MS results above, additional proteins that
selectively associated with unliganded PR compared with
their liganded counterparts were identified by RPPA
(Table 3-1).
Ingenuity pathway analysis of PR interactome
Network pathways of proteins that associate with PR,
as identified by MS and RPPA, were created using Inge-
nuity Pathway Analysis, a program that generates protein
networks using known protein interactions (Fig. 4). The
highest scoring network pathway depicted shows pro-
teins known to associate with PR (e.g., NCOA1 and
NCOA2) and novel interactions of proteins from brain
(e.g., synapsins and tubulin complexes) with PR identified
in the present study (Fig. 4).
The use of the two proteomics approaches, MS and
RPPA, enabled a more comprehensive identification of
novel and known proteins that interacted with PR-A and
PR-B in a ligand-dependent manner. Although MS anal-
ysis of PR-protein pull-down assays is an unbiased ap-
proach, it is less sensitive than RPPA for detection of
lower-abundance proteins such as SRC-1 and SRC-2.
RPPA, on the other hand, is an antibody-based targeted
proteomic approach and is limited to the target antigens
for which antibodies are available. For example, our RPPA
platform does not have validated antibodies to synaptic
Figure 1. Hypothalamic synapsins interact with mouse PR-A and PR-B in a ligand-dependent manner. Confirmation by Western blot
of MS findings that synapsin-Ia and synapsin-Ib (A) and synapsin-IIa and synapsin-IIb (B) associate with PR-A and PR-B in the
presence, of the PR agonist R5020. Input (0.25% of total) from hypothalamic extracts (lane 1).
Table 3. Mouse PR-A and PR-B interact with hypothalamic proteins, identified by RPPA, in a ligand-dependent manner, with
a ratio of R5020/no ligand >2 and p < 0.05.




Steroid-receptor coactivator-1 NCOA1 P70365  
Steroid receptor coactivator-2 NCOA2 Q61026  
Thyroid hormone receptor-associated protein complex MED12 A2AGH6 
c-Fosp FOS P01101 
c-Junp JUN P05627 
Kruppel-like factor 4 KLF4 Q60793 
Autophagy-related protein 3 ATG3 Q9CPX6 
Autophagy related protein 12 ATG12 Q9CQY1 
BCL2 antagonist/killer 1 BAK O08734  
Forkhead box O1 (metabolism) FOXO1 Q9R1E0  
Signal transduction
Src kinasep SRC P05480 
Signal transducer and activator of transcription 2p STAT2 Q9WVL2 
Epidermal growth factor receptor EGFR Q01279 
p70S6 kinasep KS6B Q8BSK8 
Integrin-5 ITA5 P11688 
Cyclin C CCNC Q62447 
pProteins identified with phospho-specific antibodies. Table 3-1 shows proteins identified by RPPA that associate with PR in the absence of ligand.
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proteins, the largest functional groups identified by MS.
Therefore, MS and RPPA served as complementary ap-
proaches for identification of PR-interacting proteins.
Effects of progesterone and estradiol on synapsin-I–
and PSD95-containing synapses
To understand whether P4 could alter synapsin-I levels,
primary rat cortical neurons with a mature morphology
(DIV 23–25) were treated with 1 nM P4, 1 nM E2, or 1 nM P4
and E2 for 24 h. Subsequently, cells were fixed and
immunostained for synapsin-I, postsynaptic density pro-
tein 95 (PSD95), and MAP2 (marker of neuronal morphol-
ogy). Quantitative analysis of immunofluorescence revealed
that after exposure to P4, there was an increase in the
linear density of synapsin-I puncta (Fig. 5A, B). E2, on the
other hand, did not alter synapsin-I linear density from
control (vehicle) levels; the combined treatment of P4 and
E2 also had no effect on synapsin-I levels (synapsin-I
puncta linear density per 10 m: control, 13.0  0.71; P4,
16.6  0.53; E2, 14.2  0.49; P4  E2, 11.6  0.58; Fig.
5A, B). When we examined levels of the postsynaptic
protein PSD95, no change in linear density was observed
in cells treated with P4. However, an increase in the
PSD95 linear density was observed in cells treated with
E2 or P4 plus E2 (PSD95 puncta linear density per 10 m:
control, 10.7  0.85; P4, 13.1  0.69; E2, 16.6  0.68;
P4  E2, 16.4  0.74; Fig. 5A, C). We next sought to
determine whether the changes in synaptic protein linear
density induced by P4, E2, or P4 plus E2 treatments
reflected an overall change in synapse number; synapses
were defined as synapsin-I puncta overlapping with
PSD95. In line with the observed increases in synapsin-I
and PSD95 linear density in P4- and E2-treated cells, re-
spectively, an increase in synapse number was also ob-
served, whereas the combined treatment of P4 and E2 did
not alter synapse number from control levels (synaptic puncta
Figure 2. SRC-1 and SRC-2 from hypothalamus interact with PR in a ligand-dependent manner. Western blot results show that
SRC-1 (A) and SRC-2 (B) from mouse hypothalamus associate with PR-A and PR-B in the presence of the agonist R5020, but not
in the absence of ligand. p  0.05 indicates difference between the presence and absence of the ligand.
Figure 3. Hypothalamic FoxO1 interacts with mouse PR-A and PR-B when bound to the agonist, R5020. Confirmation of RPPA
findings by Western blot that FoxO1 from mouse hypothalamus associates with PR-A and PR-B in the presence, but not the absence,
of the PR agonist R5020. Inputs (1% of total) of FoxO1 from hypothalamic extracts (lane 1).
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linear density per 10 m: control, 9.9  0.80; P4, 14.3  0.49;
E2, 14.2  0.51; P4  E2, 12.15  0.59; Fig. 5A, D).
Discussion
Using the proteomics-based approaches of MS and
RPPA, we have identified proteins from female mouse
hypothalamus that form complexes with PR-A, PR-B, or
both in a ligand-dependent manner. Of the proteins that
associated with agonist-bound PR, synaptic modulators
made up the largest group, providing evidence for novel
roles of PR in synaptic plasticity. Furthermore, in primary
cortical neuronal cultures, we provide evidence that pro-
gesterone increases synapses containing synapsin-I pro-
tein, which selectively associated with ligand-bound PR.
The other major protein groups from hypothalamus that
interacted with the PR isoforms are kinases and signaling
proteins, transcriptional and translational regulators, and
proteins linked to energy metabolism.
PR and synaptic modulation
Progestins modulate dendritic spine density and syn-
apse numbers in the female rat hippocampus, ventrome-
dial hypothalamus (VMH), and prefrontal cortex, and in
cultured rat cortical neurons (Woolley and McEwen, 1993;
McEwen and Woolley, 1994; Chen et al., 2009; Griffin
et al., 2010; Chisholm and Juraska, 2012; Sanchez et al.,
2013). Most prior studies have examined the combined
effects of E2 and P4 on dendritic spines, revealing that E2
increases, whereas E2 plus P4 decreases, dendritic
spines in the hippocampus (McEwen and Woolley, 1994;
Murphy and Segal, 2000), prefrontal cortex (Chisholm and
Juraska, 2012), and hypothalamus (Griffin et al., 2010).
Previously, it has been shown that P4 treatment for 2 wks
increases dendritic spine density in cortical pyramidal
neurons of ovariectomized rats (Chen et al., 2009). The
present findings extended those of Chen et al. (2009) to
reveal that treatment with P4 for 24 h increases synapses
in cortical neurons, as indicated by immunohistochemical
localization of synapsin-I and PSD95 in the newly formed
synapses. In further support of progestin-dependent syn-
apse modulation, estradiol-induced PR have been de-
tected in neuronal processes in the hypothalamus
(Blaustein et al., 1988) and dendritic spines and axon
terminals in the hippocampus (Waters et al., 2008; Mitter-
ling et al., 2010) of female rodents.
Figure 4. Network generated by Ingenuity Pathway Analysis (IPA) showing proteins from hypothalamus that associate with liganded
PR-A and PR-B. Shaded proteins were identified to associate with both PR-A and PR-B (blue), PR-A only (green), or PR-B only
(orange) in the present study. Unshaded proteins (white) were added to the network based on curated relationships in the IPA
database. BAK1, BCL2 antagonist/killer 1; DSP, desmoplakin; JUP, junction plakoglobin; Hbbb1, hemoglobin subunit -1; HNRNPDL,
heterogeneous nuclear ribonucleoprotein D-like; NCOA1/SRC-1, steroid receptor coactivator-1; NCOA2/SRC-2, steroid receptor
coactivator-2; PGR, progesterone receptor; SNCA, -synuclein; SYN, synapsin; TUB, tubulin; YWHAZ, 14-3-3 protein /.
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The present findings, that synaptic proteins from mouse
brain interact with PR, provide insight into novel mecha-
nisms for progestin effects on synaptic functions. As iden-
tified by MS and Western blot, synapsin-I and synapsin-II
interacted with both PR isoforms in a ligand-dependent
manner. In addition, P4 increased synaptic density in rat
primary cortical neurons, indicated by an increase in syn-
apsin-I–positive puncta, suggesting that synapsin-I func-
tion in P4-mediated synapse addition is conserved among
species. The present findings confirm the synaptogenic
role of progestins and suggest a function for synapsin-I in
progestin-mediated synapse formation. Synapsins may
influence cortical synapses through direct association
with PR or, alternatively, may function with PR indirectly or
through PR-independent pathways.
Synapsins, including synapsin-I and synapsin-II, are
presynaptic phosphoproteins that are integral in axon
formation, synaptic maturation, transmission, and remod-
eling in excitatory synapses (Chin et al., 1995; Ferreira
et al., 1998; Bogen et al., 2009; Cesca et al., 2010).
Synapsins contain binding sites for MAPK/Erk and src
kinase (Jovanovic et al., 1996; Foster-Barber and Bishop,
1998), kinases identified in the present study to interact
with ligand-bound PR. Taken together, these findings
suggest that PR increase synapses through regulating
expression, transport, or phosphorylation of synapsins.
Given the rapid effects of estrogens on synapses via
kinases and synaptic proteins (Srivastava et al., 2008;
Sellers et al., 2015), it will be important to explore the
function of kinases identified here on progestin-mediated
synapse formation.
Multiple synaptic proteins interacted with PR in an
isoform-specific manner. For example, synaptogyrin-III,
which is upregulated in the hypothalamus by estradiol
(Malyala et al., 2005), interacted only with PR-A, suggest-
ing a role for this protein in hormone-dependent synaptic
changes. Synapsin-III, which is expressed in cell bodies of
neuronal progenitors and has been implicated in neuro-
genesis (Kao et al., 2008), interacted only with PR-B,
indicating a role for PR-B in neurogenesis (Barha et al.,
2011; Bali et al., 2012). Interestingly, tubulins, which are
components of microtubules that provide structural
framework for synaptic junctions, postsynaptic densities,
and synaptic vesicles (Kelly and Cotman, 1978; Zisapel
et al., 1980), formed complexes with PR in an isoform-
specific and ligand-dependent manner, another novel
finding of the current study. Tubulin-2A and tubulin-4B,
which are upregulated by estradiol in female hippocam-
pus, were associated with liganded PR in the present
study (Pechenino and Frick, 2009; Sárvári et al., 2015).
Taken together, these findings suggest an important role
for tubulins in progestin-mediated synaptic plasticity in
the brain.
PR and signal transduction
PR, acting through kinase activation, exert rapid effects
in the brain (Mani et al., 2006; Tetel, 2009; Sanchez et al.,
2013). In further support of rapid effects of PR in the brain,
we found that MAPK1 associated with liganded PR-B,
but not PR-A. Consistent with these findings, MAPK1
associates with and phosphorylates PR-B, but not PR-A,
in P4-treated breast cancer cells (Clemm et al., 2000;
Figure 5. Progesterone (P4) and estradiol (E2) alter synapse number and synaptic protein expression. A, Representative confocal
images of primary rat cortical neurons treated with 1 nM P4, 1 nM E2, or both for 24 h. Images are for synapsin-I (green) and PSD95
(red) along MAP2-positive dendrites (blue). Open arrowheads indicate colocalized synapsin-I and PSD95 puncta and thus, synapses.
B, Quantitative analysis of synapsin-I linear density; treatment with P4 increased synapsin-I density compared with control (vehicle)
condition. C, PSD95 linear density was increased over control levels after treatment with E2 alone or combined P4 and E2 treatment.
D, Measurement of synaptic puncta, defined as synapsin-I puncta positive for PSD95, was increased after treatment with either P4
or E2. p  0.01; p  0.001; scale bar  5 m.
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Boonyaratanakornkit et al., 2007). In addition, we de-
tected hormone-dependent interactions between src ki-
nase and EGFR with PR-A, but not PR-B. These
differential interactions of signaling molecules with PR
may be important for isoform-specific rapid effects of PR
in brain.
PR and energy metabolism
Although the profound effects of estradiol on decreas-
ing feeding and weight gain and increasing activity in
women and female rodents is well known (Blaustein and
Wade, 1976; Clegg, 2012; Bless et al., 2014, 2016), the
effects of progesterone on metabolism are less studied.
However, progesterone attenuates the effects of estro-
gens on food intake and carbohydrate metabolism in
female primates and women, respectively (Kemnitz et al.,
1989; D’Eon et al., 2002; Michopoulos and Wilson, 2011).
The present findings reveal that creatine kinase B and
phytanoyl COA-hydroxylase interacting protein-like, both
involved in energy metabolism (James et al., 2012;
Schlattner et al., 2016), associated with PR-A, but not
PR-B, implicating a function for hypothalamic PR-A in
energy homeostasis.
In further support of PR function in energy homeostasis,
the transcriptional regulator FoxO1 interacted with both
PR isoforms. FoxO1 is expressed in energy regulation
centers, including the VMH and arcuate nucleus (Kim
et al., 2006; Fukuda et al., 2008), and enhances food
intake by increasing neuropeptide Y and agouti-related
protein mRNA expression (Kitamura et al., 2006; Huang
et al., 2012). In addition, FoxO1 attenuates leptin signaling
and is regulated by leptin (Yang et al., 2009; Ren et al.,
2013). Taken together with the studies above, the present
findings suggest that hypothalamic PR function in energy
homeostasis and indicate the need for further study of
progestins in food intake and energy metabolism.
PR and transcriptional regulation
PR-A and PR-B act as transcription factors in concert
with other transcriptional regulators, including nuclear re-
ceptor coactivators and RNA polymerases (O’Malley
et al., 2012; Tetel and Acharya, 2013; Dasgupta et al.,
2014). The present findings reveal that SRC-1 and SRC-2
from hypothalamus interact with agonist-bound PR-A and
PR-B, consistent with our earlier work that these coacti-
vators are coexpressed with the PR isoforms in the female
mouse hypothalamus (Acharya et al., 2015) and function
in the brain to modulate PR-dependent behaviors (Molenda-
Figueira et al., 2006).
Although the role of the transcription factor FoxO1 in
energy metabolism is discussed above, it has also been
linked to stress and depression. FoxO1 expression is
upregulated by glucocorticoids (Qin et al., 2014) and is
downregulated by antidepressants (Polter et al., 2009).
Thus, exploring a potential role of FoxO1 and PR interac-
tion may provide more insight into the role of progester-
one in stress disorders.
PR-A, but not PR-B, interacted with MED12, which
bridges transcription factors with RNA polymerases and is
integral for vertebrate neuronal development (Wang et al.,
2006; Rocha et al., 2010; Kim et al., 2016). In humans,
MED12 mutations lead to X-linked mental retardation
(Philibert et al., 2001; Risheg et al., 2007; Schwartz et al.,
2007). Taken together, the present findings provide a
mechanism by which progestins mediate brain develop-
ment (Quadros et al., 2008; López and Wagner, 2009)
through PRA-MED12 interactions. In future studies, it will
be important to explore whether mutations in MED12
disrupt interactions with PR and alter brain development.
Based on previous studies and the current findings, a
majority of tubulins and synaptic proteins, including syn-
apsin isoforms and -synuclein, likely associate with PR
through a 26S proteasome complex as shown by Ingenu-
ity Pathway Analysis (Fig. 4). Interestingly, 26S protease
subunit associated with PR-B, but not PR-A, in the current
study, suggesting differential downregulation of the PR
isoforms after P4 treatment (Lange et al., 2000). Ingenuity
Pathway Analysis incorporates previously identified pro-
teins that are known to associate with PR, in either the
liganded or unliganded state, with the present findings.
For example, proteins known from previous studies to
interact with PR, including a molecular chaperone hsp90
(DeMarzo et al., 1991; Johnson et al., 1994; Tetel et al.,
1997), actin (known for its role in PR- mediated growth
cone formation and modulation of dendritic spines; San-
chez et al., 2013; Wessel et al., 2014), and nuclear
factor-B (a stress-response regulator; Cutolo et al.,
2004), were added to the network (Fig. 5) by Ingenuity
Pathway Analysis. However, given that the present study
focused on hypothalamic proteins that interact with PR in
a ligand-dependent manner, only these proteins from the
current findings were added to the network (shaded pro-
teins in Fig. 5). In summary, this network confirms previ-
ously known interactions of PR with nuclear receptor
coactivators (e.g., SRC-1/NCOA1 and SRC-2/NCOA2)
and provides evidence for novel mechanisms by which
progestins modulate synapses, revealing multiple regula-
tory levels of PR action in the brain.
Although genome-wide analysis of PR binding sites in
mouse uterus (Rubel et al., 2012) and computational mod-
els have been used to predict the human PR interactome
(Liu et al., 2015), to the best of our knowledge, the PR
interactome has not been previously analyzed. Despite
different approaches used in the previous studies (Rubel
et al., 2012; Liu et al., 2015), the present findings of
association of PR with transcriptional regulators, multiple
tubulin isoforms, Src kinase, and EGFR were consistent
with these published reports. Other studies have focused
on receptor-dependent transcriptome or proteome of ste-
roid receptors, including PR and estrogen receptors (Tan
et al., 2012; Yang et al., 2017). Finally, proximity mapping
has been used in cultured cells to identify proteins show-
ing ligand-dependent interactions with receptors for glu-
cocorticoids and androgens (Lempiäinen et al., 2017).
Although these studies have found some interacting part-
ners similar to those of the present study, including
SRC-1, SRC-2, and MED12, none of these experiments
investigated interacting proteins from the brain, and more
specifically the hypothalamus. Therefore, the current
study has identified a number of novel proteins interacting
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with PR, including synaptic proteins and regulators of
metabolism.
A comprehensive and novel approach of combining
MS and RPPA enabled us to identify a diverse and new
group of protein complexes in the brain that interact
with PR in a ligand- and isoform-specific manner. Al-
though MS is an unbiased approach for identification of
novel proteins, it requires large amounts of protein
input, which could result in difficulty identifying low-
abundance proteins. RPPA complemented the MS and
expanded the coverage for low-abundance proteins.
Both approaches identified many proteins in three ma-
jor groups, including those with roles in transcription,
metabolism, and signal transduction. In future studies,
it will be important to investigate interactions between
endogenous hypothalamic PR with proteins using dif-
ferent approaches (e.g., coimmunoprecipitation as-
says) to confirm and extend the current findings.
Through the identification of multiple components of PR
complexes in the brain, the current study provides in-
sights into various mechanisms of PR in physiology and
disease. In addition, identification of protein complexes
from female mouse hypothalamus that interact differen-
tially with PR-A and PR-B sheds light on mechanisms that
may contribute to PR isoform–specific functions. This
study provides a novel role for synapsin-I in progestin-
induced increase in synapses. These findings offer further
evidence for overlapping pathways in genomic and non-
genomic regulation in synaptic physiology and energy
metabolism. In future studies, it will be important to apply
the present strategies to identify factors involved in
ligand-independent activation of PR (Denner et al., 1990;
Mani et al., 1994; Tetel and Lange, 2009) that will provide
important insights into PR action in physiology, behavior,
and disease.
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